236 related articles for article (PubMed ID: 12851684)
1. A2B5 lineages of human astrocytic tumors and their recurrence.
Xia CL; Du ZW; Liu ZY; Huang Q; Chan WY
Int J Oncol; 2003 Aug; 23(2):353-61. PubMed ID: 12851684
[TBL] [Abstract][Full Text] [Related]
2. Dual lineage of astrocytomas.
Bishop M; de la Monte SM
Am J Pathol; 1989 Sep; 135(3):517-27. PubMed ID: 2551172
[TBL] [Abstract][Full Text] [Related]
3. Uniform lineage of oligodendrogliomas.
de la Monte SM
Am J Pathol; 1989 Sep; 135(3):529-40. PubMed ID: 2675625
[TBL] [Abstract][Full Text] [Related]
4. Nucleolar organizer regions (AgNORs) in astrocytic tumors.
Pedal WP; Warzok RW; Hufnagl P; Roth K
Zentralbl Pathol; 1994 Mar; 140(1):89-94. PubMed ID: 7515679
[TBL] [Abstract][Full Text] [Related]
5. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
Reyaz N; Tayyab M; Khan SA; Siddique T
J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
[TBL] [Abstract][Full Text] [Related]
6. Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation.
Haapasalo H; Isola J; Sallinen P; Kalimo H; Helin H; Rantala I
Am J Pathol; 1993 May; 142(5):1347-51. PubMed ID: 7684193
[TBL] [Abstract][Full Text] [Related]
7. Characterization and transformation potential of "Synthetic" astrocytes differentiated from murine embryonic stem cells.
Kamnasaran D; Hawkins C; Guha A
Glia; 2008 Mar; 56(4):457-70. PubMed ID: 18205175
[TBL] [Abstract][Full Text] [Related]
8. Reduced latency but no increased brain tumor penetrance in mice with astrocyte specific expression of a human p53 mutant.
Klein MA; Rüedi D; Nozaki M; Dell EW; Diserens AC; Seelentag W; Janzer RC; Aguzzi A; Hegi ME
Oncogene; 2000 Nov; 19(47):5329-37. PubMed ID: 11103934
[TBL] [Abstract][Full Text] [Related]
9. Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression.
Wilhelmsson U; Eliasson C; Bjerkvig R; Pekny M
Oncogene; 2003 May; 22(22):3407-11. PubMed ID: 12776191
[TBL] [Abstract][Full Text] [Related]
10. In vitro identification and functional characterization of glial precursor cells in human gliomas.
Colin C; Baeza N; Tong S; Bouvier C; Quilichini B; Durbec P; Figarella-Branger D
Neuropathol Appl Neurobiol; 2006 Apr; 32(2):189-202. PubMed ID: 16599947
[TBL] [Abstract][Full Text] [Related]
11. Ganglioside (GD2) expression and intermediary filaments in astrocytic tumors.
Mennel HD; Lell B
Clin Neuropathol; 2005; 24(1):13-8. PubMed ID: 15696779
[TBL] [Abstract][Full Text] [Related]
12. J1-31 protein expression in astrocytes and astrocytomas.
Shuangshoti S; Thorner PS; Ruangvejvorachai P; Saha B; Groshen S; Taylor CR; Malhotra S; Imam SA
Neuropathology; 2009 Oct; 29(5):521-7. PubMed ID: 19019178
[TBL] [Abstract][Full Text] [Related]
13. Low-grade astrocytomas may arise from different astrocyte lineages.
Piepmeier JM; Fried I; Makuch R
Neurosurgery; 1993 Oct; 33(4):627-32. PubMed ID: 8232801
[TBL] [Abstract][Full Text] [Related]
14. [The analysis of nuclear organizer regions of astrocytomas with various histologic malignancies].
Tokiyoshi K; Yoshimine T; Maruno M; Nakagawa H; Iwata Y; Kuroda R; Hayakawa T
No To Shinkei; 1992 Dec; 44(12):1083-6. PubMed ID: 1296727
[TBL] [Abstract][Full Text] [Related]
15. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor.
Choi KC; Kwak SE; Kim JE; Sheen SH; Kang TC
Neurosci Lett; 2009 Oct; 463(3):182-7. PubMed ID: 19647039
[TBL] [Abstract][Full Text] [Related]
16. Establishment, characterization, and evolution of cultures enriched in type-2 astrocytes.
Aloisi F; Agresti C; Levi G
J Neurosci Res; 1988; 21(2-4):188-98. PubMed ID: 3216420
[TBL] [Abstract][Full Text] [Related]
17. Contactin is expressed in human astrocytic gliomas and mediates repulsive effects.
Eckerich C; Zapf S; Ulbricht U; Müller S; Fillbrandt R; Westphal M; Lamszus K
Glia; 2006 Jan; 53(1):1-12. PubMed ID: 16078236
[TBL] [Abstract][Full Text] [Related]
18. Patterns of expression of TSC-22 protein in astrocytic gliomas.
Shostak KO; Dmitrenko VV; Vudmaska MI; Naidenov VG; Beletskii AV; Malisheva TA; Semenova VM; Zozulya YP; Demotes-Mainard J; Kavsan VM
Exp Oncol; 2005 Dec; 27(4):314-8. PubMed ID: 16404353
[TBL] [Abstract][Full Text] [Related]
19. Expression of tumor necrosis factor-alpha cachectin in primary brain tumors of astrocytic lineage.
Liberski PP; Mirecka B; Alwasiak J; Yanagihara R; Gajdusek DC
Neuropatol Pol; 1992; 30(1):35-42. PubMed ID: 1484608
[TBL] [Abstract][Full Text] [Related]
20. Nucleolar organizer regions (AgNORs) in primary and recurrent gliomas. A retrospective study.
Engel U; Plate K; Jänisch W; Mennel HD
Zentralbl Pathol; 1994 Mar; 140(1):73-81. PubMed ID: 7515677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
